Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK

This page shows the latest Cancer Research UK news and features for those working in and with pharma, biotech and healthcare.

Greater Manchester backs move to outcome-based payment

Greater Manchester backs move to outcome-based payment

Region teams up with Cancer Research UK to accelerate change. Moves towards paying for medicines according to patient outcomes are taking off in the US and Europe, with healthcare systems and ... Now England’s leading devolved health region, Greater

Latest news

  • Bicycle Therapeutics to tackle AMR with government funding Bicycle Therapeutics to tackle AMR with government funding

    The Small Business Research Initiative (SBRI) awards companies that identify new ideas and technologies that address future challenges to the NHS. ... modulators. The company’s lead programme, BT1718, is being evaluated in a phase 1/2a trial in

  • Neoantigen player Achilles gets OK for first clinical trial Neoantigen player Achilles gets OK for first clinical trial

    trial of its candidate for advanced non-small cell lung cancer (NSCLC) after getting a green light from the MHRA. ... Achilles launched in 2016 with funding of just over £13m ($17m) as an offshoot from life sciences  group Syncona and Cancer Research

  • AZ and CRUK launch Cambridge genomics centre AZ and CRUK launch Cambridge genomics centre

    New centre adds to Cambridge's biotech cluster. AstraZeneca has unveiled an ambitious expansion of its alliance with Cancer Research UK (CRUK), the partners today launching a new genomics research centre ... Mene Pangalos, Executive Vice President,

  • UK life sciences gets some Brexit relief with £1.3bn sector deal UK life sciences gets some Brexit relief with £1.3bn sector deal

    £50m to expand its UK presence, including a new global headquarters, and Celgene has set aside £22m for a five-year drug discovery collaboration with Cancer Research UK. ... CRUK is also pitching in with a £14m investment in a London unit for cancer

  • NICE lung cancer backing for Keytruda is biggest expansion yet NICE lung cancer backing for Keytruda is biggest expansion yet

    NHS. Prof Charles Swanton. Medical charity Cancer Research UK (CRUK) also welcomed the news. ... Lung cancer is the biggest cancer killer in the UK so it’s vital that innovations like this reach patients as quickly as possible.”.

More from news
Approximately 15 fully matching, plus 120 partially matching documents found.

Latest Intelligence

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    A recent review of the current landscape of clinical research in cancer immunotherapy counted more than 3, 000 trials enrolling patients, including more than 1, 000 trials evaluating combinations with ... This view is shared by Professor Charles Swanton,

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    Scientists from the UK’s Medical Research Council Laboratory of Molecular Biology – which pioneered the sequencing of DNA – are already working with AstraZeneca counterparts and they will have places in the ... The park is also home to the Cancer

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    up innate immune responses, and Cancer Research UK is repurposing an AZ chemokine CCR4 receptor drug (AZD2098) originally developed for asthma in kidney cancer. ... Additional work is going to stratify tumours according to these molecular signatures, and

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of

  • Communicating health messages Communicating health messages

    Consider this impactful infographic from Cancer Research UK:. Now take a look at how such comparisons are normally presented in the media. ... them? They are human too.  . Source: Cancer Research UK  . How data is framed can incite behaviour change .

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Glythera has appointed new chief scientific officer Dr Robert Lutz to lead the advancement of the UK-based biotech's antibody drug conjugate portfolio. ... Additionally, Dr Jon Roffey joins Glythera’s scientific advisory board (SAB) from Cancer

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Workman currently serves The Institute of Cancer Researc h as its president and chief executive officer and has formerly served as head of the division of cancer therapeutics at Cancer Research ... world class cancer institute and being a founder of

  • Cancer Research UK's Karen Vousden to join BMS board Cancer Research UK's Karen Vousden to join BMS board

    Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January. ... Vousden is currently chief scientist at Cancer Research UK, as well as serving as group leader at the Francis Crick Institute in London, will

  • Sophie Adlard joins J+D Consulting as a business analyst Sophie Adlard joins J+D Consulting as a business analyst

    She brings experience from Cancer Research UK, where she was a PhD student. ... market research and forecasting projects going forward.”.

  • Hollingsworth leaves cancer charity for ABPI Hollingsworth leaves cancer charity for ABPI

    Andrew Hollingsworth appointed policy manager at pharma industry body. Andrew Hollingsworth is to leave the third sector to join industry, moving from Cancer Research UK to the Association of the British ... He leaves his role as public affairs manager

More from appointments
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • International Childhood Cancer Day 2019

    We've pulled together an infographic to show just what we mean with data c/o Cancer Research UK (CRUK) and a great initiative by Beads of Courage, Inc. ... There's still more to do, so show your support for a day when there is No More Pain and No More

  • World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer

    In spite of this, pancreatic cancer research is chronically underfunded and awareness is low, in part because of widespread misconceptions regarding the disease. ... Indeed, the disease receives only 3% of UK cancer research funding [6], and a patient

  • World Cancer Day and the role of people-centred care

    Overview on Patient Centricity in Cancer Care. Front Pharmacol 2017; 8: 1-12. ... BMJ Innov 2017; 3(2): 76-83. World Cancer Day. Available at: . Accessed February 2018. Cancer Research UK. Available at: . Accessed February 2018.

  • Caring for prostate cancer patients

    Cancer Research UK estimates that  men in the UK have a 1 in 8 chance of developing prostate cancer  at some point in their lives. It’s the most commonly diagnosed ... cancer in men and campaigns such as ‘ Movember’ have been effective in

  • Why is the UK lagging behind the rest of Europe in cancer survival?

    Say Communications, London healthcare PR agency, discusses the latest technologies that will improve cancer survival rates in UK. ... Cancer survival rates are thankfully rising but the UK has been  reported  as falling behind the rest of Europe.

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics